We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lung Cancer Survivors Receive Too Many PET Scans

By MedImaging International staff writers
Posted on 08 Mar 2016
Lung and esophageal cancer survivors undergo excessive positron emission tomography (PET) scans during follow-up care with no impact on survival, claims a new study.

Researchers at the University of Michigan (U-M; Ann Arbor, USA), and Dartmouth-Hitchcock Medical Center (Lebanon, NH, USA) searched the US Surveillance, Epidemiology, and End Results (SEER) register to identify 97,152 primary lung and 4,446 esophageal cancer patients with follow-up data, using patient and tumor characteristics to calculate risk-adjusted two-year overall survival. Using Medicare claims, they then examined PET utilization in person-years, excluding scans for staging and for follow-up of CT findings, and stratified hospitals by quintiles of PET utilization for adjusted two-year survival analysis.

The results showed a statistically significant variation in utilization of PET scans, ranging from 0.05 to 0.70 scans per person-year for lung cancer and 0.12 to 0.97 scans per person-year for esophageal cancer. But despite the statistically significant variation in use of PET to detect tumor recurrence, there was no association with improved two-year survival, suggesting possible overuse of PET for recurrence detection, which current Medicare policy would not appear to substantially affect. The study was published on February 22, 2016, in the Journal of the National Cancer Institute.

“PET scanning is a great technology and very effective, but using it in this way doesn't seem to make any difference for these cancers that have a relatively poor prognosis,” said lead author Mark Healy, MD, of U-M. “Following evidence-based guidelines for clinical follow-up is the way to go; don't order PET in asymptomatic patients. And for patients, if you are not having symptoms and you're doing well, there's no reason to seek out this scan.”

PET scans are often used for staging, restaging, and monitoring of cancer patients for treatment response. They are also often used to detect recurrence in asymptomatic patients, despite a lack of evidence demonstrating improved survival. The US Centers for Medicare & Medicaid Services (CMS; Baltimore, MD, USA) impose a limit of three follow-up PET scans per person, even when doctors only order them following a computerized tomography (CT) or other medical imaging procedure.

Related Links:

University of Michigan
Dartmouth-Hitchcock Medical Center
The US Centers for Medicare & Medicaid Services


Mobile X-Ray System
K4W
Breast Localization System
MAMMOREP LOOP
X-Ray Generator
Advantage Plus Generators
Digital Color Doppler Ultrasound System
MS22Plus

Channels

General/Advanced Imaging

view channel
Image: Example snapshots of the photon energy density at t = 0.5, 0.7, 0.9, 1.1 nanoseconds (ns) on the y = 2.0 cm plane (Horie, S., Yajima, H., Abe, M. et al., Biomedical Engineering Letters (2026). DOI: 10.1007/s13534-026-00578-9)

AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection

Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.